Articles

  • 3 weeks ago | ophthalmologytimes.com | Andrew Lee |Andrew Carey

    CommentaryVideoApril 2, 2025Author(s):,Fact checked by:Andrew G. Lee, MD, and Drew Carey, MD, return for this episode of 'NeuroOp Guru' to discuss how sixth nerve palsy with chemosis warrants suspicion for a cavernous carotid fistula, emphasizing careful examination for dilated conjunctival vessels and the need for imaging for accurate diagnosis and timely intervention. This latest episode of the “NeuroOp Guru”—hosted by Andrew G.

  • 1 month ago | ophthalmologytimes.com | Andrew Lee |Andrew Carey

    This latest episode of the “NeuroOp Guru”—hosted by Andrew G. Lee, MD, from Houston Methodist, and joined by Drew Carey, MD, from Johns Hopkins University—features a retrospective study1 on somatic mitochondrial mutations and their variable neuro-ophthalmic manifestations. Mitochondrial diseases are typically inherited maternally, but mutations can also arise post-fertilization and affect specific tissues.

  • Jan 20, 2025 | healio.com | Andrew Lee |Eamon Dreisbach |Nancy Hemphill

    Source: Lee AG, et al. Subspecialty update: Deadly and dangerous mimics in neuro-ophthalmology. Presented at: Hawaiian Eye 2025; Jan. 18-24, 2025; Koloa, Hawaii. Disclosures: Lee reports no relevant financial disclosures.

  • Jan 12, 2025 | ophthalmologytimes.com | Andrew Carey |Andrew Lee

    Commentary Video January 12, 2025 Author(s): , Andrew Lee, MD, and Andrew Carey, MD, sit down on another episode of the NeuroOp Guru to discuss deep learning systems and whether they can distinguish between optic disc drusen and true papilledema Andrew Lee, MD, and Andrew Carey, MD, sit down on another episode of the NeuroOp Guru to discuss deep learning systems and whether they can distinguish between optic disc drusen and true papilledema Video Transcript Editor's note - This transcript has...

  • Oct 15, 2024 | ophthalmologytimes.com | Andrew Lee

    Alzheimer's disease (AD) is the leading cause of dementia, with approximately 6.5 million individuals in the US aged 65 years or older currently living with AD. It was also ranked as the sixth-leading cause of death in 2022. Projections indicate that the number of individuals in this age group affected by AD could reach 12.7 million by 2050.1,2AD is a neurodegenerative disease characterized by neuronal loss in the cerebral cortex and the formation of extracellular plaques.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →